NewslettersPulmonary Cell NewsUncategorizedComparative Study on the Efficacy and Exposure of Molecular Target Agents in Non–small Cell Lung Cancer PDX Models with Driver Genetic AlterationsBy Justin.choi - January 27, 2022019Scientists selected five NSCLC patient-derived xenografts (PDXs) with genetic alterations from established PDXs and the corresponding molecular targeted therapy was administered orally for 21 consecutive days.[Molecular Cancer therapeutics] 7992332 {7992332:AAAAAAAA} apa 50 1 171165 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Abstract